IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.226
EU - Europa 34.098
AS - Asia 26.697
SA - Sud America 5.488
Continente sconosciuto - Info sul continente non disponibili 805
AF - Africa 668
OC - Oceania 149
Totale 127.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 55.522
SG - Singapore 9.644
IT - Italia 8.006
GB - Regno Unito 7.328
RU - Federazione Russa 7.234
CN - Cina 6.701
BR - Brasile 4.261
VN - Vietnam 3.649
CA - Canada 2.554
UA - Ucraina 2.337
DE - Germania 2.317
HK - Hong Kong 1.984
BD - Bangladesh 1.759
DK - Danimarca 1.535
FR - Francia 1.139
SE - Svezia 1.081
FI - Finlandia 836
IN - India 569
IE - Irlanda 556
PL - Polonia 540
MX - Messico 481
AR - Argentina 439
NL - Olanda 395
TR - Turchia 327
IL - Israele 283
ID - Indonesia 258
EC - Ecuador 228
IQ - Iraq 216
ZA - Sudafrica 212
PK - Pakistan 209
JP - Giappone 208
ES - Italia 194
CO - Colombia 149
VE - Venezuela 122
CR - Costa Rica 121
AT - Austria 115
AU - Australia 113
EU - Europa 106
UZ - Uzbekistan 100
MA - Marocco 98
SA - Arabia Saudita 91
CL - Cile 88
KR - Corea 77
GT - Guatemala 72
HN - Honduras 72
IR - Iran 72
AE - Emirati Arabi Uniti 71
JM - Giamaica 71
PY - Paraguay 67
TT - Trinidad e Tobago 67
EG - Egitto 66
MY - Malesia 66
KE - Kenya 64
LT - Lituania 63
SV - El Salvador 61
PH - Filippine 60
PE - Perù 57
TN - Tunisia 52
NI - Nicaragua 51
RO - Romania 49
JO - Giordania 46
DZ - Algeria 43
BE - Belgio 41
CH - Svizzera 41
PR - Porto Rico 40
NP - Nepal 37
BO - Bolivia 36
PT - Portogallo 36
SK - Slovacchia (Repubblica Slovacca) 34
GP - Guadalupe 33
NZ - Nuova Zelanda 33
UY - Uruguay 33
TH - Thailandia 32
AZ - Azerbaigian 31
ET - Etiopia 30
CZ - Repubblica Ceca 29
KZ - Kazakistan 27
CW - ???statistics.table.value.countryCode.CW??? 26
GR - Grecia 23
TW - Taiwan 23
DO - Repubblica Dominicana 18
KG - Kirghizistan 18
HU - Ungheria 17
OM - Oman 17
PA - Panama 17
PS - Palestinian Territory 17
AL - Albania 16
QA - Qatar 15
BB - Barbados 14
EE - Estonia 14
GE - Georgia 13
AM - Armenia 12
LV - Lettonia 12
NO - Norvegia 12
RS - Serbia 12
BY - Bielorussia 11
MK - Macedonia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
Totale 126.214
Salva come PNG Salva come JPEG
Città #
Dallas 8.086
Southend 4.837
Singapore 4.814
San Jose 3.763
Ashburn 3.755
Beijing 2.762
Woodbridge 2.678
Council Bluffs 2.426
Chandler 2.320
Ann Arbor 2.295
Houston 2.140
Hong Kong 1.761
Fairfield 1.627
San Mateo 1.470
Moscow 1.302
Falls Church 1.263
Los Angeles 1.171
Jacksonville 1.116
Seattle 1.102
Milan 1.063
Dearborn 1.020
Ho Chi Minh City 993
Cambridge 971
Wilmington 902
Ottawa 869
New York 814
The Dalles 796
Rome 770
Chicago 668
Pisa 657
Santa Clara 657
Hanoi 631
Boardman 564
Hefei 541
Dublin 521
Lauterbourg 513
Stevenage 512
Portsmouth 503
Warsaw 493
Dong Ket 483
Buffalo 478
São Paulo 474
Helsinki 425
Montréal 403
Lawrence 386
Phoenix 371
Brooklyn 336
Beauharnois 315
London 261
Tel Aviv 250
Orem 245
Munich 244
Florence 239
Montreal 239
Salt Lake City 236
Mexico City 214
Toronto 204
Naples 185
Frankfurt am Main 184
San Diego 179
Redwood City 175
Atlanta 168
Tokyo 168
Denver 163
Columbus 158
Old Bridge 158
Stockholm 153
Chennai 150
Istanbul 148
Rio de Janeiro 145
Figino 140
Poplar 139
Da Nang 134
Amsterdam 133
Johannesburg 132
Bologna 126
Turin 122
Haiphong 119
Boston 118
Tampa 118
Elk Grove Village 115
Nuremberg 115
Fremont 112
Manchester 98
San Francisco 91
Washington 91
Tashkent 90
San José 88
Ankara 78
Shanghai 77
Bari 75
Brasília 75
Belo Horizonte 74
Biên Hòa 72
Curitiba 71
Mumbai 71
Norwalk 71
Charlotte 70
Quito 70
Guayaquil 69
Totale 76.037
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.732
Value in Healthcare and the Role of the Patient Voice 1.249
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 712
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 648
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 633
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 532
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 520
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 512
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 510
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 478
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 468
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 444
A simple echocardiographic score to rule out cardiac amyloidosis 432
A simple echocardiographic score to rule out cardiac amyloidosis 412
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 411
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 409
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 404
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 388
Human pathophysiological adaptations to the space environment 385
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 382
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 373
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 371
The evolution of TAVI performance overtime: an overview of systematic reviews 370
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 368
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 366
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 365
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 362
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 360
[Central apneas and cardiovascular diseases] 358
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 354
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 354
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 352
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 351
La neuropatia diabetica 350
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 350
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 350
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 348
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 347
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 347
Prediction of the chemoreflex gain by common clinical variables in heart failure 347
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 346
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 345
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 344
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 343
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 343
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 341
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 340
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 340
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 338
Treating chemoreflex in heart failure: modulation or demolition? 337
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 334
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 334
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 333
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 333
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 329
Adrenergic activation in heart failure: blockade or rebalance? 326
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 325
Eligibility for vericiguat in a real‐world, contemporary heart failure population 323
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 320
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 320
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 320
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 319
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 319
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 318
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 318
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 316
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 316
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 316
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 315
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 315
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 315
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 314
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 314
RNA-targeting and gene editing therapies for transthyretin amyloidosis 313
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 313
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 313
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 312
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 312
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 312
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 311
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 310
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 310
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 310
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 308
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 308
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 307
Screening the health status of people working in a university 305
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 304
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 303
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 303
Sex-related differences in chronic heart failure 302
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 301
How to take arms against central apneas in heart failure 301
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 301
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 300
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 299
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 299
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 298
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 297
Totale 37.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 634.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 634.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.789 0 0 0 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.021 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.382 3.296 2.254
2025/202650.993 2.656 8.064 5.647 6.140 5.315 3.007 5.759 2.098 2.691 3.249 3.143 3.224
2026/20279.400 1.320 1.718 3.068 3.294 0 0 0 0 0 0 0 0
Totale 127.131